Flucloxacillin Sodium 250mg Capsule Franchise in Ahmedabad

Antibiotic Capsule Supplier in Bangalore

Flucloxacillin Capsule Distributor in Hyderabad

Bacterial Infection Capsule Franchise Opportunity in Jaipur

Penicillin Antibiotic Capsule Stockist in Mumbai
Flucloxacillin Capsule Export & Manufacturing in Chandigarh

Home/Products /flucloxacillin-sodium-250mg-capsule

Fluxacillin 250 Capsule

Composition : Flucloxacillin Sodium (250mg) Capsule

Dosage Form : Capsule

Packaging Type : Blister

Packaging : 10*10

Price : ₹1/-

Fluxacillin 250 Capsule contains Flucloxacillin Sodium 250mg, a beta-lactam antibiotic specifically effective against penicillinase-producing staphylococci. It is widely prescribed for treating skin and soft tissue infections, bone and joint infections, respiratory tract infections, and other susceptible bacterial conditions.

This formulation provides reliable antibacterial action by inhibiting bacterial cell wall synthesis, leading to effective elimination of infection-causing organisms. The 250mg capsule strength is commonly used in mild to moderate infections, offering dependable therapeutic outcomes with good patient tolerability.

For hospitals, clinics, and pharmaceutical distributors, Fluxacillin 250 Capsule is a regularly prescribed antibiotic, frequently required in general practice, surgical care, dermatology, and orthopedic departments. Continuous incidence of bacterial infections ensures stable demand and consistent repeat orders.

Adding Fluxacillin 250 Capsule to your product portfolio strengthens your anti-infective and general medicine segment, opening opportunities in hospital procurement, pharmacy distribution, institutional supply, export markets, and third-party manufacturing. Its clinical reliability and consistent prescription pattern make it a commercially valuable product for pharmaceutical distributors.

Read More

About the Product

Fluxacillin 250 Capsule contains Flucloxacillin Sodium 250mg, a beta-lactam antibiotic specifically effective against penicillinase-producing staphylococci. It is widely prescribed for treating skin and soft tissue infections, bone and joint infections, respiratory tract infections, and other susceptible bacterial conditions.

This formulation provides reliable antibacterial action by inhibiting bacterial cell wall synthesis, leading to effective elimination of infection-causing organisms. The 250mg capsule strength is commonly used in mild to moderate infections, offering dependable therapeutic outcomes with good patient tolerability.

For hospitals, clinics, and pharmaceutical distributors, Fluxacillin 250 Capsule is a regularly prescribed antibiotic, frequently required in general practice, surgical care, dermatology, and orthopedic departments. Continuous incidence of bacterial infections ensures stable demand and consistent repeat orders.

Adding Fluxacillin 250 Capsule to your product portfolio strengthens your anti-infective and general medicine segment, opening opportunities in hospital procurement, pharmacy distribution, institutional supply, export markets, and third-party manufacturing. Its clinical reliability and consistent prescription pattern make it a commercially valuable product for pharmaceutical distributors.

Some patients may experience nausea, vomiting, diarrhea, abdominal discomfort, or skin rash. Rarely, liver enzyme elevation, jaundice, or allergic reactions may occur.

Fluxacillin 250 Capsule is indicated for the treatment of skin and soft tissue infections, bone and joint infections, respiratory tract infections, and other infections caused by susceptible bacteria, especially Staphylococcus species.

Use strictly under medical supervision. Avoid in patients with known hypersensitivity to penicillins or beta-lactam antibiotics. Complete the full prescribed course to prevent resistance. Use with caution in patients with liver impairment.

Store in a cool, dry place below 25°C, protected from light and moisture. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation